What are you looking for?


Bringing the vision of your drug to life, SGS PACE is a streamlined pathway for molecules from clinical formulation to First in Human (FIH) and Proof of Concept (POC).
SGS Chemical Laboratory Testing Hurth Germany

World-leading development, bioanalysis and clinical research –through one point of contact

SGS PACE is an exclusive service, offering an expert-directed roadmap, from preclinical and formulation to clinic, through one dedicated program manager. SGS PACE maximizes your drug potential through enabled formulations at preclinical and clinical stages to enhance bioavailability/solubility.

Discover the benefits of SGS PACE

SGS PACE enables you to:

  • Gain a streamlined pathway – from preclinical testing right through to FIH/POC
  • Enjoy a combination of world-leading development and clinical research through one point of contact
  • Improve flexibility, efficiency, and speed in your drug development
  • Get real-time data – adapting decision making for fast clinic feedback to optimize the formulation
  • Reduce overall program time, from preclinical to FIH/POC, with defined expert supported review points
  • Ensure that your project is efficient and on track. Your dedicated program manager provides you with complete oversight of all stages of your bespoke pathway
  • Access comprehensive scientific, medical, and quality reviews throughout your project to support decision making and your objectives
SGS Clinical Pharmacology Unit Antwerp Belgium

Fully dedicated program manager

Your dedicated SGS PACE program manager provides coordination and milestone review points with the relevant subject matter experts, including:

  • An initial clinical development consultancy plan
  • Preclinical formulation and bioanalysis (to ensure you are FIH ready)
  • Clinical formulation/analysis/manufacturing
  • FIH dosing
  • Bioanalysis and data analysis and reporting
  • Evaluation and optimization of the formulation in clinic, based on human data
  • Hybrid FIH including POC in a small patient population
  • Phase II clinical development approach and management

What does the SGS PACE service offer

An integrated team of experts to streamline molecules’ pathway

You can benefit from a comprehensive scientific, medical, and high-quality review throughout your project to support decision-making and achieving your key objectives.

  • A seamless service:

    SGS PACE brings together all the phases of drug development that would traditionally be handled by separate organizations and vendors, greatly improving efficiency.

  • Strategic consultancy:

    SGS PACE also offers strategic consultancy and ongoing support from our global network of experts. Our consultants will work with you to build a custom service and advise you from formulation stages all the way through to FIH / POC.

  • Program management:

    A dedicated program manager will work in collaboration with your teams and SGS’s network to provide custom strategies, time frames and cost management to match your needs and budget.

  • Improved flexibility:

    SGS PACE offers full flexibility in the selection, optimization and adjustment of drug formulations. Additionally, it removes the challenge of conflicting timelines from different vendors, along with cascading delays, resulting in a more agile, resilient process.

We're delighted to unveil this service, aimed at enhancing efficiency and streamlining the clinical development journey for our valued customers.

At SGS, innovation is at the heart of everything we do. This initiative is a testament to our commitment to pioneering solutions that allow our clients to gain competitive advantage.

Executive Vice President, Connectivity & Products and Health & Nutrition at SGS

Charles LY WA HOI

SGS Network

Our network of formulation, clinical research, and clinical manufacturing solutions offers a wide range of integrated services and expertise across America and Europe. 

Our experts are ready to support you throughout the development and commercial manufacture of your drug product, helping you ensure the delivery of safe, effective, and compliant medicines to global markets.

Get in touch with our experts

Our team will provide you with the solutions you need to bring your drug to life.
Mike Frodsham

Mike Frodsham

Chief Technology Officer for SGS Quay

Wim Verreth

Head of Business Development and Support for Clinical Research, SGS
Follow our Health Science Community on LinkedIn

Industriepark 2B,


Merelbeke, Belgium